Cellular experiments revealed that overexpression of CDK1 substantially reversed the proliferation inhibition observed upon CD2BP2‐DT knockdown in breast cancer cells (Figure 7D,E; Figure S6B,C, Supporting Information). The gene discussed is CD2BP2; the disease is breast cancer.